Skip to main content

Dr. Brett E. Fortune, M.D.

Hepatology (Hepatology Physician)

  • Medicare participating

At a glance

Years since graduation
22
In the NPI registry since
2007
Medicare patients seen, 2024
90

Licensed in Connecticut since 2012, according to the Connecticut Department of Public Health. We show license dates only for the states that publish them in bulk; see which states do. For other states, check the state medical board.

The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is

Education and training

  • 2004Medical school: Wake Forest University School of Medicine
  • 2007Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier

Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).

Specialties and state licenses

  • Hepatology Physician primary
    NY license 283730
  • Gastroenterology Physician
    CT license 051154 (first issued 2012; active)
  • Internal Medicine Physician
    OH license 35088963
  • Transplant Hepatology Physician
    FL license ME177299

As reported to the NPI registry. To confirm a license is current, check the state medical board.

Map: Hepatology per capita by county →

Where they work

Hospitals

Medical groups

Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.

Medicare patients and services

Medicare patients, 2024
90
Services billed
188
Patients’ average age
71
Most frequent Medicare services, 2023
ServiceTimesPatients
Established patient office or other outpatient visit, 40-54 minutes1816
Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes1716
Measurement of liver stiffness1414

Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.

Medicare prescriptions

Most prescribed drugs, Medicare Part D 2024
DrugPrescriptions
Ursodiol
Other prescribers in Miami, FL
35
Carvedilol
Other prescribers in Miami, FL
26
Tenofovir Disoproxil Fumarate22
Spironolactone
Other prescribers in Miami, FL
15

Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.

Payments from drug and device companies

In 2025, 9 companies reported 45 payments worth $56,594 in total to this clinician.

By company
Novo Nordisk Inc$27,091
Madrigal Pharmaceuticals$14,635
W. L. Gore & Associates, Inc.$6,180
Bard Peripheral Vascular, Inc.$4,031
Bausch Health US, LLC$3,654
Gilead Sciences, Inc.$717
Mallinckrodt Hospital Products Inc.$142
Mirum Pharmaceuticals, Inc.$95.43
By type
Compensation for services other than consulting (speaking, faculty)$37,891
Consulting Fee$14,073
Food and Beverage$2,472
Travel and Lodging$2,158

What the payments were for

Largest payments other than meals
DateCompanyWhat it was forAmount
Dec 4, 2025Novo Nordisk Inc
Dec 4, 2025
Compensation for services other than consulting (speaking, faculty)
Wegovy · Obesity
$9,616
Dec 17, 2025Novo Nordisk Inc
Dec 17, 2025
Compensation for services other than consulting (speaking, faculty)
Wegovy · Obesity
$9,224
Oct 10, 2025Novo Nordisk Inc
Oct 10, 2025
Compensation for services other than consulting (speaking, faculty)
Wegovy · Obesity
$5,505
Apr 9, 2025Madrigal Pharmaceuticals
Apr 9, 2025
Compensation for services other than consulting (speaking, faculty)
REZDIFFRA · LIVER DISEASE
$4,515
Feb 11, 2025Madrigal Pharmaceuticals
Feb 11, 2025
Compensation for services other than consulting (speaking, faculty)
REZDIFFRA · LIVER DISEASE
$3,548
Apr 16, 2025Madrigal Pharmaceuticals
Apr 16, 2025
Compensation for services other than consulting (speaking, faculty)
REZDIFFRA · LIVER DISEASE
$3,548
May 8, 2025Bausch Health US, LLC
May 8, 2025
Consulting Fee$3,200
Mar 6, 2025Bard Peripheral Vascular, Inc.
Mar 6, 2025
Consulting Fee$2,275
Aug 13, 2025Madrigal Pharmaceuticals
Aug 13, 2025
Compensation for services other than consulting (speaking, faculty)
REZDIFFRA · LIVER DISEASE
$1,935
Feb 28, 2025W. L. Gore & Associates, Inc.
Feb 28, 2025
Consulting Fee
VIATORR Endoprosthesis · Devices
$1,770
All 20 payments other than meals, newest first
All payments other than meals
DateCompanyWhat it was forAmount
Dec 17, 2025Novo Nordisk Inc
Dec 17, 2025
Compensation for services other than consulting (speaking, faculty)
Wegovy · Obesity
$9,224
Dec 17, 2025Novo Nordisk Inc
Dec 17, 2025
Travel and Lodging
Wegovy · Obesity · travel to Melbourne, FL · in-kind
$1,123
Dec 4, 2025Novo Nordisk Inc
Dec 4, 2025
Compensation for services other than consulting (speaking, faculty)
Wegovy · Obesity
$9,616
Dec 4, 2025Novo Nordisk Inc
Dec 4, 2025
Travel and Lodging
Wegovy · Obesity · travel to Hollywood, FL · in-kind
$751
Nov 24, 2025Bard Peripheral Vascular, Inc.
Nov 24, 2025
Consulting Fee$1,625
Nov 3, 2025Novo Nordisk Inc
Nov 3, 2025
Consulting Fee
Multiple Therapeutic Areas
$393
Oct 17, 2025W. L. Gore & Associates, Inc.
Oct 17, 2025
Consulting Fee
GORE VIATORR TIPS Endoprosthesis · Devices
$660
Oct 17, 2025W. L. Gore & Associates, Inc.
Oct 17, 2025
Consulting Fee
GORE VIATORR TIPS Endoprosthesis · Devices
$330
Oct 10, 2025Novo Nordisk Inc
Oct 10, 2025
Compensation for services other than consulting (speaking, faculty)
Wegovy · Obesity
$5,505
Aug 13, 2025Madrigal Pharmaceuticals
Aug 13, 2025
Compensation for services other than consulting (speaking, faculty)
REZDIFFRA · LIVER DISEASE
$1,935
Jul 7, 2025W. L. Gore & Associates, Inc.
Jul 7, 2025
Consulting Fee
GORE VIATORR TIPS Endoprosthesis with Controlled Expansion · Devices
$1,650
May 9, 2025Bausch Health US, LLC
May 9, 2025
Consulting Fee$400
May 8, 2025Bausch Health US, LLC
May 8, 2025
Consulting Fee$3,200
Apr 16, 2025Madrigal Pharmaceuticals
Apr 16, 2025
Compensation for services other than consulting (speaking, faculty)
REZDIFFRA · LIVER DISEASE
$3,548
Apr 9, 2025Madrigal Pharmaceuticals
Apr 9, 2025
Compensation for services other than consulting (speaking, faculty)
REZDIFFRA · LIVER DISEASE
$4,515
Mar 6, 2025Bard Peripheral Vascular, Inc.
Mar 6, 2025
Consulting Fee$2,275
Mar 1, 2025Gilead Sciences, Inc.
Mar 1, 2025
Travel and Lodging
Epclusa · HCV · travel to Atlanta, GA · in-kind
Company’s description;4026684;GTF;11431757
$284
Feb 28, 2025W. L. Gore & Associates, Inc.
Feb 28, 2025
Consulting Fee
VIATORR Endoprosthesis · Devices
$1,770
Feb 28, 2025W. L. Gore & Associates, Inc.
Feb 28, 2025
Consulting Fee
VIATORR Endoprosthesis · Devices
$1,770
Feb 11, 2025Madrigal Pharmaceuticals
Feb 11, 2025
Compensation for services other than consulting (speaking, faculty)
REZDIFFRA · LIVER DISEASE
$3,548

Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.

From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.

Who received the most in Florida →

Industry-funded research

Named as a principal investigator on 2 industry-funded studies in 2025, from 2 companies. The companies reported $69,195 in research payments for these studies, mostly to the institutions running them.

  • A Two Part Phase IIa b Multicentre, Randomised, Double-Blind, Placebo-Controlled, Parallel Group Dose-ranging Study to Assess Efficacy, Safety, and Tolerability of the Combination of Zibotentan and Dapagliflozin, and …
    AstraZeneca Pharmaceuticals LP
  • Study to Assess Rifaximin Soluble Solid Dispersion (SSD) for the Delay of Encephalopathy Decompensation in Cirrhosis (RED-C-3132)
    Bausch Health US, LLC

From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.

Other Hepatology clinicians in Miami

Sources

NPI registry (CMS NPPES, November 2026; record last updated October 20, 2025), Medicare Care Compare, Medicare Physician & Other Practitioners (2024), Medicare Part D Prescribers (2024) and Open Payments (2025). Information is self-reported or billed data and may be out of date; call before visiting.

NPI 1720121585. Official NPI registry record (opens in a new tab). Clinicians can correct their information in NPPES; changes appear here after our next monthly update.